NQMC Update Service: March 23, 2015 ▲ Quality Measurement, Evaluation, Testing, Review, and Implementation Consortium (Q-METRIC)

NQMC Update Service: March 23, 2015

Quality Measurement, Evaluation, Testing, Review, and Implementation Consortium (Q-METRIC)

• Sickle cell disease (SCD): percentage of children 5 through 17 years of age identified as having SCD who received anticipatory guidance regarding school attendance/performance as part of outpatient care during the measurement year.

• Sickle cell disease (SCD): percentage of children younger than 18 years of age identified as having SCD and on a chronic transfusion program who received monitoring of hemoglobin S levels immediately prior to each transfusion during the measurement year.

• Sickle cell disease (SCD): percentage of children younger than 18 years of age identified as having SCD presenting to an ED with an acute pain episode who had a pain assessment within 30 minutes following initial contact during the measurement year.

• Sickle cell disease (SCD): percentage of children younger than 18 years of age identified as having SCD presenting to an ED with fever who received parenteral broad-spectrum antibiotic treatment within 60 minutes following initial contact during the measurement year.

• Sickle cell disease (SCD): percentage of children younger than 18 years of age identified as having SCD presenting to an ED with fever, who had a pulse oximetry reading, complete blood count, reticulocyte count, and blood culture within 60 minutes following initial contact during the measurement year.

• Sickle cell disease (SCD): percentage of children younger than 18 years of age identified as having SCD presenting to an ED with severe pain who had a pain assessment within 30 minutes following analgesic administration during the measurement year.

• Sickle cell disease (SCD): percentage of children younger than 18 years of age identified as having SCD presenting to an ED with severe pain who had a parenteral analgesic within 60 minutes following initial contact during the measurement year.

• Sickle cell disease (SCD): percentage of children younger than 18 years of age identified as having SCD who had: (1) a pulse oximetry reading, (2) a complete blood count, and (3) a reticulocyte count performed within the same 7-day period as part of outpatient care during the measurement year.

• Sickle cell disease (SCD): percentage of children younger than 18 years of age identified as having SCD who received anticipatory guidance regarding the identification, prevention and/or management of stroke/silent infarcts as part of outpatient care during the measurement year.

• Sickle cell disease (SCD): percentage of children younger than 18 years of age identified as having SCD who received anticipatory guidance regarding the prevention and/or management of fever and severe infection as part of outpatient care during the measurement year.

• Sickle cell disease (SCD): percentage of children younger than 18 years of age identified as having SCD who received anticipatory guidance regarding the prevention and/or management of pain as part of outpatient care during the measurement year.

• Sickle cell disease (SCD): percentage of children younger than 18 years of age identified as having sickle cell anemia who received anticipatory guidance regarding the risks and benefits of treatment with hydroxyurea as part of outpatient care during the measurement year.

• Sickle cell disease (SCD): percentage of children younger than 4 years of age identified as having SCD who received anticipatory guidance regarding the identification, prevention, and/or management of splenic complications as part of outpatient care during the measurement year.